Literature DB >> 20104272

Foetal haemoglobin inducers and thalassaemia: novel achievements.

Roberto Gambari.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20104272      PMCID： PMC2809505          DOI： 10.2450/2009.0137-09

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  13 in total

Review 1.  Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia.

Authors:  Roberto Gambari; Eitan Fibach
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

2.  Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy.

Authors:  Nicoletta Masera; Luisa Tavecchia; Marietta Capra; Giovanni Cazzaniga; Chiara Vimercati; Lorena Pozzi; Andrea Biondi; Giuseppe Masera
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

3.  Thalidomide therapy in a patient with thalassemia major.

Authors:  Lilia Beatriz Aguilar-Lopez; José Luis Delgado-Lamas; Benjamín Rubio-Jurado; Francisco Javier Perea; Bertha Ibarra
Journal:  Blood Cells Mol Dis       Date:  2008-04-24       Impact factor: 3.039

4.  Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients.

Authors:  Eitan Fibach; Nicoletta Bianchi; Monica Borgatti; Cristina Zuccato; Alessia Finotti; Ilaria Lampronti; Eugenia Prus; Carlo Mischiati; Roberto Gambari
Journal:  Eur J Haematol       Date:  2006-08-24       Impact factor: 2.997

Review 5.  Molecular diagnosis of inherited disorders: lessons from hemoglobinopathies.

Authors:  George P Patrinos; Panagoula Kollia; Manoussos N Papadakis
Journal:  Hum Mutat       Date:  2005-11       Impact factor: 4.878

6.  Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation.

Authors:  C M Rodrigue; N Arous; D Bachir; J Smith-Ravin; P H Romeo; F Galacteros; M C Garel
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

7.  A novel frameshift mutation (+A) at codon 18 of the beta-globin gene associated with high persistence of fetal hemoglobin phenotype and deltabeta-thalassemia.

Authors:  Giordana Feriotto; Francesca Salvatori; Alessia Finotti; Giulia Breveglieri; Marina Venturi; Cristina Zuccato; Nicoletta Bianchi; Monica Borgatti; Ilaria Lampronti; Irene Mancini; Francesco Massei; Claudio Favre; Roberto Gambari
Journal:  Acta Haematol       Date:  2008-01-30       Impact factor: 2.195

8.  An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: the Euro-mediterranean ITHANET project.

Authors:  Carsten W Lederer; A Nazli Basak; Yesim Aydinok; Soteroula Christou; Amal El-Beshlawy; Androulla Eleftheriou; Slaheddine Fattoum; Alex E Felice; Eitan Fibach; Renzo Galanello; Roberto Gambari; Lucian Gavrila; Piero C Giordano; Frank Grosveld; Helen Hassapopoulou; Eva Hladka; Emmanuel Kanavakis; Franco Locatelli; John Old; George P Patrinos; Giovanni Romeo; Ali Taher; Joanne Traeger-Synodinos; Panayiotis Vassiliou; Ana Villegas; Ersi Voskaridou; Henri Wajcman; Anastasios Zafeiropoulos; Marina Kleanthous
Journal:  Hemoglobin       Date:  2009       Impact factor: 0.849

Review 9.  Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies.

Authors:  Ugo Testa
Journal:  Ann Hematol       Date:  2008-11-15       Impact factor: 3.673

10.  Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.

Authors:  Nicoletta Bianchi; Cristina Zuccato; Ilaria Lampronti; Monica Borgatti; Roberto Gambari
Journal:  Evid Based Complement Alternat Med       Date:  2007-12-11       Impact factor: 2.629
View more
  1 in total

1.  A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.

Authors:  Cristina Zuccato; Laura Breda; Francesca Salvatori; Giulia Breveglieri; Sara Gardenghi; Nicoletta Bianchi; Eleonora Brognara; Ilaria Lampronti; Monica Borgatti; Stefano Rivella; Roberto Gambari
Journal:  Ann Hematol       Date:  2012-03-31       Impact factor: 3.673
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.